GSA CAPITAL PARTNERS LLP - ADAMIS PHARMACEUTICALS CORP ownership

ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 43 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of ADAMIS PHARMACEUTICALS CORP
ValueSharesWeighting
Q4 2020$250,000
+468.2%
516,203
+825.9%
0.04%
+485.7%
Q3 2020$44,000
+120.0%
55,752
+99.4%
0.01%
+133.3%
Q3 2019$20,000
-89.0%
27,958
-80.0%
0.00%
-85.0%
Q2 2019$181,000139,6050.02%
Other shareholders
ADAMIS PHARMACEUTICALS CORP shareholders Q4 2020
NameSharesValueWeighting ↓
BARD ASSOCIATES INC 124,300$87,0000.04%
Hayden Royal, LLC 16,000$12,272,0000.01%
Global Strategic Investment Solutions, LLC 23,000$16,0000.01%
Founders Capital Management 8,000$6,0000.01%
Cable Hill Partners, LLC 20,000$14,0000.00%
Jacobi Capital Management LLC 25,000$18,0000.00%
Stonebridge Capital Advisors LLC 22,000$15,0000.00%
B. Riley Wealth Advisors, Inc. 37,520$27,0000.00%
Firestone Capital Management 5,200$4,0000.00%
MGO ONE SEVEN LLC 10,615$7,0000.00%
View complete list of ADAMIS PHARMACEUTICALS CORP shareholders